Marco Sardina

Marco Sardina

Directeur/Membre du Conseil chez Amypopharma Srl

Health Technology
Finance
Consumer Services

Profil

At Panakes since 2021, physician by education and training, with a PhD in Clinical Pharmacology, Marco brings over thirty years of international experience, in leading clinical research projects from Phase I to IV, R&D, Medical Affairs team, supporting Business Development and in/out licensing processes.
Well-recognized expert in drug discovery & development with proven record of advancing projects from discovery to proof-of-concept in clinical stage and marketing approval in different fields.
He has three-year experience as Partner in a Corporate Venture company and 5 years as CSO in BiovelocITA an innovative Biotech focused accelerator.
Marco is Scientific Advisory Board member in innovative startups, author of more than 140 scientific publications and four patents.
He is Fellow of the International College of Angiology, member of the Faculty of Pharmaceutical Medicine and of the New York Academy of Sciences.
Education M.D.
University of Milan PhD Pharmacology University of Pavia

Postes actifs de Marco Sardina

SociétésPosteDébut
Directeur/Membre du Conseil -
Private Equity Investor 01/06/2021
Tous les postes actifs de Marco Sardina

Anciens postes connus de Marco Sardina

SociétésPosteFin
Ciba-Geigy Denmark Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
NICOX SA Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Marco Sardina

Formation de Marco Sardina

Università Di Pavia Graduate Degree
Universita Degli Studi Del Sannio Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Marco Sardina

Relations

24

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
NICOX SA

Health Technology

Entreprise privées7

Health Technology

Health Technology

Finance

Finance

Health Technology

Ciba-Geigy Denmark

Consumer Durables

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Marco Sardina